Mizuho Markets Americas LLC boosted its stake in shares of MKS Instruments, Inc. (NASDAQ:MKSI – Free Report) by 57.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 278,887 shares of the scientific and technical instruments company’s stock after purchasing an additional 101,439 shares during the period. Mizuho Markets Americas LLC owned about 0.41% of MKS Instruments worth $30,318,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the stock. Shellback Capital LP purchased a new stake in shares of MKS Instruments during the 2nd quarter worth about $34,541,000. Millennium Management LLC raised its position in MKS Instruments by 219.5% during the second quarter. Millennium Management LLC now owns 348,024 shares of the scientific and technical instruments company’s stock valued at $45,445,000 after acquiring an additional 239,099 shares in the last quarter. Artemis Investment Management LLP acquired a new stake in MKS Instruments in the third quarter valued at approximately $21,690,000. Natixis Advisors LLC grew its position in MKS Instruments by 239.2% in the second quarter. Natixis Advisors LLC now owns 247,695 shares of the scientific and technical instruments company’s stock worth $32,344,000 after acquiring an additional 174,675 shares in the last quarter. Finally, Ceredex Value Advisors LLC increased its stake in shares of MKS Instruments by 41.2% during the 2nd quarter. Ceredex Value Advisors LLC now owns 432,858 shares of the scientific and technical instruments company’s stock worth $56,523,000 after purchasing an additional 126,200 shares during the last quarter. Institutional investors and hedge funds own 99.79% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the stock. Needham & Company LLC upped their price objective on shares of MKS Instruments from $153.00 to $156.00 and gave the stock a “buy” rating in a report on Friday, August 9th. The Goldman Sachs Group began coverage on MKS Instruments in a report on Tuesday, September 3rd. They set a “neutral” rating and a $129.00 price objective on the stock. Citigroup lowered MKS Instruments from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $145.00 to $120.00 in a report on Monday, September 16th. Mizuho raised MKS Instruments to a “strong-buy” rating in a research report on Monday, October 7th. Finally, Cantor Fitzgerald began coverage on shares of MKS Instruments in a research report on Tuesday, September 10th. They issued an “overweight” rating and a $140.00 price target on the stock. Five analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, MKS Instruments has an average rating of “Moderate Buy” and an average target price of $141.09.
MKS Instruments Price Performance
MKS Instruments stock opened at $105.48 on Friday. The business has a 50 day simple moving average of $106.81 and a 200 day simple moving average of $118.81. The company has a debt-to-equity ratio of 1.98, a current ratio of 3.42 and a quick ratio of 2.21. The company has a market capitalization of $7.10 billion, a PE ratio of 234.40, a price-to-earnings-growth ratio of 0.66 and a beta of 1.63. MKS Instruments, Inc. has a one year low of $75.07 and a one year high of $147.40.
MKS Instruments (NASDAQ:MKSI – Get Free Report) last issued its earnings results on Wednesday, November 6th. The scientific and technical instruments company reported $1.72 EPS for the quarter, beating the consensus estimate of $1.45 by $0.27. MKS Instruments had a net margin of 0.90% and a return on equity of 15.79%. The company had revenue of $896.00 million for the quarter, compared to the consensus estimate of $874.29 million. During the same quarter in the previous year, the company earned $1.46 EPS. The firm’s revenue for the quarter was down 3.9% compared to the same quarter last year. On average, sell-side analysts forecast that MKS Instruments, Inc. will post 6.22 EPS for the current fiscal year.
MKS Instruments Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 25th will be issued a dividend of $0.22 per share. The ex-dividend date of this dividend is Monday, November 25th. This represents a $0.88 dividend on an annualized basis and a yield of 0.83%. MKS Instruments’s dividend payout ratio is 195.56%.
Insider Buying and Selling at MKS Instruments
In related news, Director Elizabeth Mora sold 275 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $115.97, for a total value of $31,891.75. Following the completion of the transaction, the director now owns 17,934 shares in the company, valued at $2,079,805.98. The trade was a 1.51 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jacqueline F. Moloney sold 250 shares of the business’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $108.90, for a total value of $27,225.00. Following the sale, the director now owns 10,283 shares of the company’s stock, valued at approximately $1,119,818.70. The trade was a 2.37 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.46% of the company’s stock.
MKS Instruments Profile
MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.
Further Reading
- Five stocks we like better than MKS Instruments
- The How and Why of Investing in Gold Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Is WallStreetBets and What Stocks Are They Targeting?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Basic Materials Stocks Investing
- Time to Load Up on Home Builders?
Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.